Detalhe da pesquisa
1.
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.
Support Care Cancer
; 23(8): 2231-44, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25564221
2.
Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation.
Mediators Inflamm
; 2014: 518261, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24757285
3.
Strategies for non-resectable head and neck cancer.
Curr Treat Options Oncol
; 14(4): 492-504, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24065559
4.
The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy.
Support Care Cancer
; 20(9): 2141-7, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22081118
5.
Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions.
Oncology
; 81(1): 21-9, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21912194
6.
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
Support Care Cancer
; 19(11): 1823-30, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21560032
7.
Facial basal cell carcinomas treated with hypo-fractionated radiotherapy: A retrospective analysis in 117 elderly patients.
J Am Acad Dermatol
; 73(1): 166-8, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26089054
8.
Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach.
Cancer Rep (Hoboken)
; 3(6): e1285, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32881424
9.
Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.
Anticancer Res
; 39(4): 1935-1942, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30952736
10.
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide.
Clin Transl Radiat Oncol
; 12: 47-52, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-30186977
11.
Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
Int J Radiat Oncol Biol Phys
; 66(3): 731-7, 2006 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17011449
12.
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations.
Am J Clin Oncol
; 39(4): 407-15, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27077276
13.
Extreme hypofractionation for early prostate cancer: Biology meets technology.
Cancer Treat Rev
; 50: 48-60, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27631875
14.
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
Crit Rev Oncol Hematol
; 100: 147-66, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26947812
15.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.
Crit Rev Oncol Hematol
; 102: 47-54, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27061883
16.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
Crit Rev Oncol Hematol
; 97: 131-42, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26318095
17.
Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Radiother Oncol
; 75(2): 193-6, 2005 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16086909
18.
Facial Basal Cell Carcinomas in Elderly Frail Patients Treated with Low Total-dose Radiotherapy.
Anticancer Res
; 35(9): 4949-53, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26254393
19.
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.
Crit Rev Oncol Hematol
; 96(1): 167-82, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26187236
20.
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.
Crit Rev Oncol Hematol
; 96(2): 372-84, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26141260